Effect of simvastatin, probiotic and NAC drugs as adjuvant therapy to standard treatment in the eradication of Helicobacter pylori

Phase 2

Recruiting

• Conditions: Helicobacter pylori infection.; Helicobacter pylori [H. pylori] as the cause of diseases classified elsewhere; B96.81

• Registration Number: IRCT20220406054431N1
• Lead Sponsor: Shahid Beheshti University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 30 May 2022

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 168

Inclusion Criteria

People over the age of 18 and under 65
With positive stool antigen test or endoscopy for Helicobacter pylori

Exclusion Criteria

History of heart, kidney and liver failure
Diabetes
Developing an active cancer
Drug and alcohol addiction
Recent history of gastrointestinal bleeding
Get previous treatment

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Helicobacter pylori eradication rate. Timepoint: Beginning of the study and one month later. Method of measurement: Stool test for Helicobacter pylori antigen.